Generate Biomedicines, Inc. (GENB) at a glance

Generate Biomedicines, Inc. (GENB) is a small-cap Healthcare company. It trades at $15.36, with a 0% profit margin and revenue decline of 18.1%. It does not pay a dividend. Vestovix scores it 39/100 overall. Its strongest dimension is Value (50/100) and its weakest is Growth (22/100).

Price
$15.36
Market cap
$1.59B
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$11.00 to $22.67
Vestovix Score39/ 100How this works
Value
50
Growth
22
Income
40
Safety
46
Momentum
40

Other Healthcare stocks

See all